Popular weight loss injections including Ozempic, Wegovy and Mounjaro could increase the risk of thyroid cancer within the first year of use, concerning new research has suggested. The drugs, which have helped millions of people shed up to a fifth of their body weight,
Dilan Patel, a women's health coach said he was living his life as any other young adult when he started experiencing night sweats - and then he was diagnosed with cancer
Colon cancer remains one of the most prevalent yet often undetected forms of cancer, developing silently in the large intestine. According to recent medical
Speaking to Express.co.uk, Doctor Robin Clark - medical director at Bupa Health Insurance - warned that patients with bowel cancer might experience anaemia. This is because the person could be bleeding internally, and more specifically, bleeding from the tumour.
Although the symptoms tend to vary depending on the type, stage, and location of the disease, unexplained weight loss can sometimes indicate cancer. Cancer refers to any disease in which cells ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, not just the glucose impact of individual meals, they’ve been designed, largely thanks to Knudsen’s work, with slight changes to allow them to hang out in the blood longer than GLP-1 normally does.
Doctors say new research has found a link between weight-loss drugs and cancer, putting users at 'significantly higher risk' of the disease. The injections were originally made to tackle diabetes and research in the USA has found they come with a greater risk of cancer than other diabetes drugs.
Dr. Anna Arthur discusses how the NOURISH trial is addressing food insecurity and malnutrition in patients undergoing treatment for their blood cancers.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health condition tied to weight.
Metastatic breast cancer and breast cancer treatment can cause symptoms that produce appetite loss, but there are strategies to help. Here are the top tips.
Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based therapies and lead to significant weight loss in adults, according to top-line results from a phase 1b/2a trial.